US FDA approves Gamida’s blood cancer therapy

(Reuters) – The U.S. Food and Drug Administration has approved Gamida Cell Ltd’s blood cancer therapy, Omisirge, the health regulator said on Monday.

(Reporting by Pratik Jain in Bengaluru)